America illumina Co.
On August 24, 2015, Burning Rock and America illumina Co. (NASDDAQ: ILMN) declared a strategic cooperation in Guangzhou and San Diego officially and signed an agreement on jointly developing a tumor individualistic medical gene detection. Both sides will cooperate to develop a tumor molecular diagnosis kit geared to Chinese market and easy to operate. As part of their cooperation, Burning Rock will provide nucleic acid extraction, construction of gene bank and data analysis software, while illumina will provide NGS instrument and related reagents. America illumina Co. is a globally leading supplier of new generation of high-flux sequencing instrument, and a leading developer, manufacturer and marketer of life science kit and complete system used to analyze hereditary mutations and functions on a large scale. These systems have realized researches which we could not imagine years ago and made us nearer to the fulfillment of individualistic medicine.